Different cancers have mutations in IDH1 and IDH2, including a fraction of acute myeloid leukemia, low-grade glioma, secondary glioblastoma, chondrosarcoma, and cholangiocarcinoma [29–32]. The gene discussed is IDH1; the disease is glioma.